©2025 Bryn Mawr Communications, LLC.
All Rights Reserved

Terms and Conditions • Privacy Policy
Diabetic Retinopathy Header Bar

Editorial Feature:

Diabetic Retinopathy

Changing Treatment Paradigms

In this Feature

Updates in Changing Treatment Paradigms for DR

Translating Data for Educating Patients With DR
Translating Data for Educating Patients With DR

Arshad M. Khanani, MD, Nancy Holekamp, MD, Rishi P. Singh, MD

Anti-VEGF for DR: Implications for Clinical Practice
Anti-VEGF for DR: Implications for Clinical Practice

Arshad M. Khanani, MD, Nancy Holekamp, MD

Changing Treatment Paradigms for DR: Reviewing the Data
Changing Treatment Paradigms for DR: Reviewing the Data

Arshad M. Khanani, MD, Nancy Holekamp, MD

Reviewing the BOULEVARD Trial and RG7716
Reviewing the BOULEVARD Trial and RG7716

Arshad M. Khanani, MD, Nancy Holekamp, MD, Rishi P. Singh, MD

Think Outside the Box: Treatment Options for DR
Think Outside the Box: Treatment Options for DR

Arshad M. Khanani, MD, Nancy Holekamp, MD, Rishi P. Singh, MD

Key Takeaways for Treating Patients With DR

Anti-VEGF Therapy for Patients With Proliferative and Nonproliferative Disease
Anti-VEGF Therapy for Patients With Proliferative and Nonproliferative Disease

Nikolas J.S. London, MD, Rishi P. Singh, MD, Tarek S. Hassan, MD

How to Manage Patient Buy-In for Anti-VEGF Therapy
How to Manage Patient Buy-In for Anti-VEGF Therapy

Nikolas J.S. London, MD, Rishi P. Singh, MD, Tarek S. Hassan, MD

Take-Home Points From the BOULEVARD Trial
Take-Home Points From the BOULEVARD Trial

Nikolas J.S. London, MD, Rishi P. Singh, MD, Tarek S. Hassan, MD

New Horizons for Treatment Options for DR
New Horizons for Treatment Options for DR

Nikolas J.S. London, MD, Rishi P. Singh, MD, Tarek S. Hassan, MD

Medical Management of DR: Case Discussions

Kiss Case: Anti-VEGF Agents in a Case of PDR
Kiss Case: Anti-VEGF Agents in a Case of PDR

Caroline R. Baumal, MD, Charles C. Wykoff, MD, PhD, FACS, Szilard Kiss, MD

Chiang Case: Peripheral Neovascularization With PDR
Chiang Case: Peripheral Neovascularization With PDR

Allen Chiang, MD, Charles C. Wykoff, MD, PhD, FACS, Joseph M. Coney, MD

Coney Cases: Laser Versus Anti-VEGF Treatment for Diabetic Patients
Coney Cases: Laser Versus Anti-VEGF Treatment for Diabetic Patients

Allen Chiang, MD, Charles Fritch MD, Joseph M. Coney, MD

Baumal Case: How to Treat Active PDR Without DME
Baumal Case: How to Treat Active PDR Without DME

Interactive Supplements

Diabetic Retinopathy: Changing Treatment Paradigms (Part 2)

View Resource

Diabetic Retinopathy: Changing Treatment Paradigms (Part 1)

View Resource

About This Editorial Feature

Diabetic Retinopathy About

As a new treatment option for diabetic retinopathy, intravitreal anti-VEGF injections have been likened to slowing a moving train: similar to how steady pressure on a brake mechanism will slow a train, continued anti-VEGF injections over time may slow the disease process, if not stop it in its tracks. This series of articles and videos will explore this new treatment paradigm.

close-x